Michael R. Herman
Known title: Senior VP and General CounselCIK: 0001264140
Associated companies
Transaction History
| REG | ▲ Buy | Option Exercise | 7,459 | — | 2/12/2026 | View on chart |
| REG | ▼ Sell | Tax Withholding | 2,807 | $206K | 2/12/2026 | View on chart |
| REG | ▲ Buy | Option Exercise | 5,867 | — | 2/12/2025 | View on chart |
| REG | ▼ Sell | Tax Withholding | 1,928 | $137K | 2/12/2025 | View on chart |
| REG | ▼ Sell | Open Market | 1,000 | $70K | 8/16/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 1,689 | — | 4/6/2024 | View on chart |
| REG | ▼ Sell | Tax Withholding | 664 | $39K | 4/6/2024 | View on chart |
| REG | ▼ Sell | Tax Withholding | 1,161 | $74K | 2/15/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 3,622 | — | 2/15/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,250 | — | 2/7/2023 | View on chart |
| REG | ▼ Sell | Tax Withholding | 465 | $31K | 2/7/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 1,550 | — | 4/6/2022 | View on chart |
| REG | ▼ Sell | Tax Withholding | 377 | $27K | 4/6/2022 | View on chart |
| REG | ▼ Sell | Tax Withholding | 67 | $5K | 2/4/2022 | View on chart |
| REG | ▲ Buy | Option Exercise | 870 | — | 2/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Regency Centers Faces Analyst Adjustments Amid Rate Concerns
Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.
Regency Centers Faces Analyst Adjustments Amid Rate Concerns. Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.